Category : CLINICAL SITES | Date : Mar 29, 2019

March 2019 – Evaluation visit in Ivory Coast

From 26 to 29 March 2019, an INTENSE-TBM team performed the evaluation visit of the clinical sites and the laboratory in Ivory Coast.

The evaluation team was composed of Eva Ariza Vioque, study coordinator (IDIBAPS) and Holy Nandrianina Andriamamonjisoa (IPM).

The purpose of this visit was to assess whether the capacity needs of clinical sites and laboratories are being met and to put in place the appropriate procedures to ensure that all sites are ready to recruit patients and process samples in 2020.
In the clinical sites, the assessed items were about human resources; procedures and performance (i.e. pulmonary/CFS specimen collection, storage and shipment); infrastructure, equipment and supplies; data management and infection control.

In the laboratories, the assessed items were about human resources; procedures and performance (i.e. specimen collection, storage and shipment, GeneXpert procedures, culture procedures, drug sensibility testing…); data management; laboratory infrastructure, equipment and supplies; biosafety control and quality management system.

Dr. Frédéric Ello, international trial coordinator (PACCI) and Pr. Serge Eholie, country principal investigator (Treichville University Teaching Hospital) welcomed the INTENSE-TBM evaluation team.

In Ivory Coast, patients will be recruited at three clinical sites in Abidjan:

  • Centre Hospitalier Universitaire de Treichville
  • Centre Hospitalier Universitaire de Cocody
  • Centre Hospitalier Universitaire de Yopougon

Samples will be processed at the Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses (CeDReS).